Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1317920 | 0.85 | TDP1 (0.42) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL1317064 | 0.83 | TDP1 (0.41) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL1314725 | 0.83 | TDP1 (0.41) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL28050518 | 0.78 | LMNA (0.39) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL28033237 | 0.77 | TDP1 (0.44) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL12815922 | 0.76 | TDP1 (0.35) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL1315141 | 0.76 | TDP1 (0.35) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL1315823 | 0.76 | TDP1 (0.35) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL16707374 | 0.75 | TDP1 (0.42) | TDP1TP53CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL1992127 | 0.75 | TDP1 (0.42) | TDP1TP53CYP1A2CYP2A6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3253770-B1 | METHOD OF PRODUCING ORGANOHALOSILANES | DOW SILICONES CORP (US) | 2020-09-02 | — | — | EP | disclosed |
| EP-3253771-B1 | METHOD OF PRODUCING ORGANOHALOSILANES | DOW SILICONES CORP (US) | 2020-08-12 | — | — | EP | disclosed |
| US-20190332010-A1 | ENERGY-SENSITIVE COMPOSITION, CURED PRODUCT, AND PATTERN FORMING METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-10-31 | — | — | US | disclosed |
| US-9908903-B2 | Method of producing organohalosilanes | DOW CORNING CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-20170369514-A1 | Method Of Producing Organohalosilanes | DOW SILICONES CORPORATION | 2017-12-28 | — | — | US | disclosed |
| WO-2016126808-A1 | METHOD OF PRODUCING ORGANOHALOSILANES | DOW CORNING CORPORATION (US) | 2016-08-11 | — | — | WO | disclosed |
| WO-2016126804-A1 | METHOD OF PRODUCING ORGANOHALOSILANES | DOW CORNING CORPORATION (US) | 2016-08-11 | — | — | WO | disclosed |
| EP-1142682-A1 | METHOD FOR PRODUCING ARTICLE HAVING PREDETERMINED SURFACE SHAPE, AND OPTICAL WAVEGUIDE ELEMENT | Nippon Sheet Glass Co., Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-4099981-A | MINERAL FILLER | UNION CARBIDE CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
| US-4044037-A | COUPLING AGENTS | UNION CARBIDE CORPORATION (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190332010-A1 | ENERGY-SENSITIVE COMPOSITION, CURED PRODUCT, AND PATTERN FORMING METHOD | KCNQ5, CACNA1A, KCNQ1 | TDP1 3909/4885TP53 4228/4885CYP1A2 4167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.